UPDATE: Morgan Stanley Downgrades Legand Biotech Corp. (LEGN) to Equalweight
Tweet Send to a Friend
(Updated - January 6, 2022 7:52 AM EST)
Morgan Stanley analyst Matthew Harrison downgraded Legand Biotech Corp. (NASDAQ: LEGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded Legand Biotech Corp. (NASDAQ: LEGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
